Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
NOVO-NORDISK A/S Add to My Watchlist (NYSE: NVO) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     NOVO-NORDISK A 69.52 - (+0.00%) -
Novo Alle
DK-2880
Bagsvaerd, DM
(454) 444-8888
(454) 449-0555 fax
www.novonordisk.com
CEO Lars Rebien Sorensen
Auditor PricewaterhouseCoopers
Exchange Traded NY
ISIN Number US6701002056
CIK Number 353278
NAICS Code 325412
Business Summary
A healthcare company, which is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. It has two business segments: diabetes care and biopharmaceuticals.
Number of Employees 27,068
Share Fundamentals
Market Cap 36.60B
Shares Outstanding 526.51M
Float N/A
Short Interest 845.32K
Financial Strength
Revenue (TTM) $8,537,000,000
Earnings (TTM) $1,807,000,000
Quick Ratio 1.6:1
Current Ratio 2.4:1
Total Debt/Equity 0.04:1
Dividend Information
Yield % 1.1
Annual Dividend 0.74
Latest Dividend 0.74 (2009-03-19)
Profitability
Gross Margin N/A
EBITDA Margin N/A
Profit Margin N/A
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock Updates provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs